Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Medtronic Vascular is recalling 4 units of Sherpa NX Active Guiding Catheters due to a potential loss of primary segment material that could expose underlying stainless-steel braid wires.
Medtronic Vascular is recalling 247 units of Sherpa NX Active Guiding Catheters due to potential loss of primary segment material exposing stainless-steel braid wires.
Medtronic Vascular is recalling 26 units of Sherpa NX Active Guiding Catheters due to a potential loss of primary segment material that could expose underlying stainless-steel braid wires.
Allergan is recalling specific textured breast implants and tissue expanders following FDA safety updates regarding a higher incidence of anaplastic large cell lymphoma (BIA-ALCL).
Teleflex Medical is recalling specific lots of Hudson RCI Sheridan Preformed tracheal tubes because the 15 mm connector may disconnect from the tube, potentially causing insufficient oxygenation.
Allergan is recalling 4 million textured breast implants worldwide after FDA safety updates linked them to a higher incidence of anaplastic large cell lymphoma.
Allergan is recalling Natrelle 133 tissue expanders due to FDA safety information regarding a higher incidence of anaplastic large cell lymphoma in patients with textured breast implants.
Zimmer Biomet is recalling 8 units of Vanguard XP Tibial Trays because the locking bar may not fully engage.
Zimmer Biomet is recalling 2 units of XP-CR Tibial Trays because the locking bar may not fully engage.
Zimmer Biomet is recalling 86 units of the XP-XP Tibial Tray because the locking bar may not fully engage. The recall covers units distributed across the US and several international regions.
Zimmer Biomet is recalling 49 units of Vanguard XP Tibial Tray 83 mm because the locking bar may not fully engage.
Zimmer Biomet is recalling 74 units of Vanguard XP Tibial Trays because the locking bar may not fully engage.
Zimmer Biomet is recalling 567 units of XP-CR Tibial Trays because the locking bar may not fully engage.
Zimmer Biomet is recalling 498 XP-CR Tibial Trays because the locking bar may not fully engage.
Zimmer Biomet is recalling 110 units of Vanguard XP Tibial Trays because the locking bar may not fully engage.
Zimmer Biomet is recalling 99 units of Vanguard XP Tibial Tray 79 mm because the locking bar may not fully engage.
Allergan is recalling textured breast implants worldwide due to an increased risk of anaplastic large cell lymphoma (BIA-ALCL). Patients should consult their healthcare providers.
Allergan is recalling McGhan Croissant-Shaped Tissue Expanders because the FDA identified a higher incidence of anaplastic large cell lymphoma in patients with textured breast implants.
Allergan PLC is recalling specific textured breast implants and tissue expanders following FDA safety updates regarding a higher incidence of anaplastic large cell lymphoma (BIA-ALCL).
Allergan is recalling Natrelle tissue expanders because the FDA identified a higher incidence of anaplastic large cell lymphoma in patients with textured breast implants.
Allergan PLC is recalling McGhan BioDIMENSIONAL silicone-filled breast implants due to a higher incidence of anaplastic large cell lymphoma (BIA-ALCL) associated with textured implants.
Allergan is recalling textured Natrelle Inspira breast implants and tissue expanders following FDA safety updates linking these devices to a higher incidence of anaplastic large cell lymphoma.
Allergan PLC is recalling Natrelle 133 tissue expanders due to a higher incidence of anaplastic large cell lymphoma (BIA-ALCL) associated with textured breast implants.
Allergan PLC is recalling specific textured breast implants and tissue expanders due to a higher incidence of anaplastic large cell lymphoma (BIA-ALCL).
Aesculap Implant Systems LLC is recalling Caiman disposable articulated instruments due to a possibility that the sterility batch was insufficiently sterilized.